Chia-Lin Simmons - 11 Apr 2025 Form 4 Insider Report for Channel Therapeutics Corp (CHRO)

Reporting relationship: Director
Issuer ticker: CHRO
Reported as of: 11 Apr 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Apr 2025, 21:31:27 UTC
Prior SEC filing: 31 Mar 2025
Next SEC filing: 05 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Chia-Lin Simmons

Key filing fact

Chia-Lin Simmons filed Form 4 for Channel Therapeutics Corp (CHRO) on 15 Apr 2025.

Key facts

This page summarizes Chia-Lin Simmons's Form 4 filing for Channel Therapeutics Corp (CHRO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Apr 2025, 21:31.

Change

Previous filing in this sequence was filed on 31 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHRO transaction Derivative

Stock Option

Award

Transaction value
Shares: +25,000
Change %: +24%
Price
Shares after: 130,000
Date: 11 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $1.35
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On April 11, 2025, the Reporting Person was granted stock options to purchase 25,000 shares of common stock at an exercise price of $1.35 per share, which shall vest in full in the event of a change of control transaction.